NCT06838013

Brief Summary

This study aims to evaluate the effectiveness of transcranial direct current stimulation (tDCS) and transcutaneous electrical nerve stimulation (TENS) in augmenting the efficacy of the lower limb task-oriented training in people with stroke. It is hypothesize that lower limb motor function can be best improved by combining anodal tDCS with TENS, when compared with sham-tDCS with TENS, anodal tDCS with placebo-TENS, or control training at improving ankle muscle strength, motor control of lower limbs, walking performance, functional mobility and community integration in people with stroke.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P75+ for not_applicable stroke

Timeline
3mo left

Started Jun 2024

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Jun 2024Aug 2026

Study Start

First participant enrolled

June 17, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 20, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

July 9, 2025

Status Verified

July 1, 2025

Enrollment Period

2.2 years

First QC Date

February 16, 2025

Last Update Submit

July 3, 2025

Conditions

Keywords

transcranial direct current stimulationtranscutaneous electric nerve stimulationstrokerehabilitation

Outcome Measures

Primary Outcomes (3)

  • Paretic ankle dorsiflexor strength

    The paretic ankle dorsiflexor strength (in kilograms) is measured with a Nicholas hand-held dynamometer (model 01,160, Lafayette Instrument Company, Lafayette, IN) in supine lying position. The muscle strength will be measured twice. The average strength of the 2 trials will be recorded. A higher value indicated a better paretic ankle dorsiflexor strength.

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

  • Paretic ankle plantarflexor strength

    The paretic ankle plantarflexor strength (in kilograms) is measured with a Nicholas hand-held dynamometer (model 01,160, Lafayette Instrument Company, Lafayette, IN) in supine lying position. The muscle strength will be measured twice. The average strength of the 2 trials will be recorded. A higher value indicated a better paretic ankle dorsiflexor strength.

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

  • Fugl-Meyer Assessment of Lower Extremity (FMA-LE)

    FMA-LE is used to evaluate the lower extremity motor control, including reflexes, voluntary control of isolated movement and coordination. The scale score ranging from 0 to 34, with 17 items and ordinal scoring from 0 to 2. A higher score indicates a better lower extremity motor control.

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

Secondary Outcomes (10)

  • 10-Meter Walk Test (10MWT)

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

  • Timed 'Up and Go' test (TUG)

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

  • Lower-extremity motor co-ordination test

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

  • Gait Parameters (via GAITRite)

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

  • Berg Balance Scale (BBS)

    Baseline (0 week), Mid-intervention (3 weeks), Post-intervention (6 weeks), 1-month follow-up (10 weeks)

  • +5 more secondary outcomes

Study Arms (4)

Anodal tDCS+Bi-TENS

EXPERIMENTAL

All subjects will receive eighteen 60-minute sessions of intervention, 3 sessions per week for 6 weeks.

Device: Transcranial direct current stimulation (tDCS)Device: Bilateral Transcutaneous electrical nerve stimulation (Bi-TENS)Behavioral: Lower-limb task-oriented training

Sham-tDCS+Bi-TENS

SHAM COMPARATOR

All subjects will receive eighteen 60-minute sessions of intervention, 3 sessions per week for 6 weeks.

Device: Sham transcranial direct current stimulation (Sham-tDCS)Device: Bilateral Transcutaneous electrical nerve stimulation (Bi-TENS)Behavioral: Lower-limb task-oriented training

Anodal tDCS+placebo-TENS

PLACEBO COMPARATOR

All subjects will receive eighteen 60-minute sessions of intervention, 3 sessions per week for 6 weeks.

Control training

PLACEBO COMPARATOR

All subjects will receive eighteen 60-minute sessions of intervention, 3 sessions per week for 6 weeks.

Device: Sham transcranial direct current stimulation (Sham-tDCS)Device: Placebo transcutaneous electrical nerve stimulation (Placebo-TENS)Behavioral: Lower-limb task-oriented training

Interventions

tDCS will be delivered by a constant-current electrical stimulator (DC-stimulator; Eldith, Ilmenau, Germany). Rectangular electrodes covered with a saline-soaked sponge will be used for the anode and cathode. The anode will be placed over the leg area of the motor cortex, on the lesioned side, with the medial border of the electrode placed laterally to Cz on the international electroencephalogram 10-20 system. The cathode will be placed above the contralateral orbit. The stimulation intensity will be set at 2 mA for 30 minutes.

Anodal tDCS+Bi-TENS

Sham tDCS will be delivered by a constant-current electrical stimulator (DC-stimulator; Eldith, Ilmenau, Germany). Rectangular electrodes covered with a saline-soaked sponge will be used for the anode and cathode. The anode will be placed over the leg area of the motor cortex, on the lesioned side, with the medial border of the electrode placed laterally to Cz on the international electroencephalogram 10-20 system. The cathode will be placed above the contralateral orbit. The stimulation intensity will The stimulator will only be applied for the first and last 30 seconds.

Control trainingSham-tDCS+Bi-TENS

TENS will be delivered to the common peroneal nerve of both intact and paretic leg for 30 minutes using a 120z Dual-Channel TENS Unit (ITO Physiotherapy \& Rehabilittaion, Co, Ltd, Tokyo, Japan). The TENS stimulation will be at 100 Hz, with 0.2 ms square pulses at an intensity of twice the sensory threshold (defined as the minimum intensity at which subject reported feeling a tingling sensation and below the motor threshold as indicated by the absence of muscle twitching.

Anodal tDCS+Bi-TENSSham-tDCS+Bi-TENS

Placebo-TENS will be applied to identical-looking TENS devices, with the electrical circuit disconnected inside the devices. Placebo-TENS will be delivered to the common peroneal nerve of both intact and paretic leg for 30 minutes that set at 100 Hz, with 0.2 ms square pulses.

Control training

The lower-limb task-oriented training comprises 5 exercises for 30 minutes, namely stepping up and down, heel lift a dorsiflexed position, partial squatting, gait re-education and transition training.

Anodal tDCS+Bi-TENSControl trainingSham-tDCS+Bi-TENS

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • are between 50 and 85 years of age;
  • have had a single stroke more than 6 months and less than 15 years;
  • have at least 5 degrees of active ankle dorsiflexion in the antigravity position;
  • are able to walk 10 m independently, with or without a walking aid;
  • are able to score 6 or higher out of 10 on the abbreviated mental test;
  • have no skin allergies (e.g. redness or itchiness after application of the electrical stimulation pads) to electrical stimulation or electrodes;
  • are able to follow instructions and give informed consent.

You may not qualify if:

  • have any additional medical, cardiovascular or orthopedic conditions that would hinder their treatment or assessment;
  • have a cardiac pacemaker;
  • have aphasia or cognitive difficulties that may interfere with their comprehension of instructions;
  • have an intracerebral metal clip;
  • have a major somatosensory deficit
  • have any contraindication to tDCS;
  • are currently involved in drug studies or other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Shamay Ng, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

February 16, 2025

First Posted

February 20, 2025

Study Start

June 17, 2024

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

July 9, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations